首页> 外文OA文献 >Enhancing in vivo vascularized bone formation by cobalt chloride-treated bone marrow stromal cells in a tissue engineered periosteum model
【2h】

Enhancing in vivo vascularized bone formation by cobalt chloride-treated bone marrow stromal cells in a tissue engineered periosteum model

机译:在组织工程化的骨膜模型中通过氯化钴处理的骨髓基质细胞增强体内血管化的骨形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The periosteum plays an indispensable role in both bone formation and bone defect healing. In this study we constructed an artificial in vitro periosteum by incorporating osteogenic differentiated bone marrow stromal cells (BMSCs) and cobalt chloride (CoCl(2))-treated BMSCs. The engineered periostea were implanted both subcutaneously and into skull bone defects in SCID mice to investigate ectopic and orthotopic osteogenesis and vascularization. After two weeks in subcutaneous and four weeks in bone defect areas, the implanted constructs were assessed for ectopic and orthotopic osteogenesis and vascularization by micro-CT, histomorphometrical and immunohistochemical methods. The results showed that CoCl(2) pre-treated BMSCs induced higher degree of vascularization and enhanced osteogenesis within the implants in both ectopic and orthotopic areas. This study provided a novel approach using BMSCs sourced from the same patient for both osteogenic and pro-angiogenic purposes in constructing tissue engineered periosteum to enhance vascularized osteogenesis.
机译:骨膜在骨形成和骨缺损愈合中起着不可或缺的作用。在这项研究中,我们通过结合成骨分化的骨髓基质细胞(BMSCs)和氯化钴(CoCl(2))处理的BMSC构建了一个人工体外骨膜。将经过工程改造的骨膜植入到SCID小鼠的皮下和颅骨缺损中,以研究异位和原位成骨和血管形成。在皮下皮下两周和骨缺损区域四周后,通过微型CT,组织形态计量学和免疫组织化学方法评估植入的构建体的异位和原位成骨作用和血管形成情况。结果表明,CoCl(2)预处理的BMSCs可以在异位和原位区域的植入物中诱导更高程度的血管生成并增强成骨作用。这项研究提供了一种新颖的方法,该方法使用来自同一患者的BMSCs进行成骨和促血管生成,目的是构建组织工程化的骨膜,以增强血管化的成骨作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号